Breaking News
Ad-Free Version. Upgrade your experience. Save up to 40% More details

Michael Todd

Joined: 05/06/20

Comments by Michael Todd
Bionano Genomics Feb 12, 2021 12:13PM ET
Wow BNGO technology is surprisingly unstoppable with huge production and substantial profit growth. Hardly never possible unless @$100~200 stocks. Easily @$999 by the end of this year as no genome firm in this scale apart from one major competitors @$359.
Ocugen Feb 12, 2021 11:37AM ET
OCGN made contracts with Indian pharmaceutical firms to distribute across already. Indian government decision to approve the contract in days. Then boom @$99~499.
Ocugen Feb 12, 2021 11:20AM ET
OCGN will surprise market. Covid vaccine will restructure the biotech industry. OCGN is No. 1 to compete to major phamashutcal firms.
Luckin Coffee Feb 12, 2021 11:16AM ET
Once restructuring completed, it will bounce back to $50 in weeks. Added 10,000 more. 📈
Asensus Surgical Feb 12, 2021 11:09AM ET
TRXC Unboxing day on 24th Feb. will surprise with new advances and contracts.📈 @$15~20.
Ocugen Feb 11, 2021 5:02AM ET
OCGN Covid19 vaccine production in India is near. The announcement will make OCGN @$300 instantly.
Asensus Surgical Feb 10, 2021 3:41PM ET
It used to be $89 even before AI 5G Robotic Surgical Unit. Now it is truly worth $500~750 by the 1st half 2021.
Ocugen Feb 09, 2021 9:43AM ET
Today will end @$18~20 for Covid19 solutions and expansion globally. @$499 by 1st half 2021.
Bionano Genomics Feb 09, 2021 9:26AM ET
BNGO received huge orders from a hospital over $25 millions. Imagine all hospitals world wide. BNGO will be one and only solutions with all the significant patents.
Bionano Genomics Feb 09, 2021 5:08AM ET
BNGO is most under valued stock. Grand scale solutions for Covid19 and alike virus. Genome solutions for living being's wellness. Should be @$999~ by 2023.
Ocugen Feb 09, 2021 4:52AM ET
Covid19 Vaccine for India and eventually worldwide. At least @$1,000 based on the number of shares.
Ocugen Feb 08, 2021 3:52PM ET
No production. It should be @$7.5 max.
Ocugen Feb 08, 2021 3:38PM ET
Only announced to develop. It will be back down to ********tomorrow... Get the profit and run away...
Castor Maritime Feb 08, 2021 3:26PM ET
Conclusions. 1. @$0.15 as technically -@$3.45 2. No orders 3. Turkey Risks 4. Extensive liabilities 5. SEC closing to OTC market 6. More huge competitors in Mediterranean
Asensus Surgical Feb 08, 2021 2:48PM ET
TRXC ISU is far superior than any robotic surgical system in the world and yet 25,000% cheaper than the competitors. Should see @$499 by 1st half 2021.
Asensus Surgical Feb 08, 2021 11:26AM ET
TRXC is most advanced AI, 5G and Robotic based futuristic surgical system. Global distributions are coming. @$999 by 2022.
Vyne Therapeutics Feb 08, 2021 11:21AM ET
BlackRock has world top class analysts and their unanimous decision on VYNE was huge investment. Surely it's about 1000s% growth expectation.
Check Cap Ltd Feb 08, 2021 11:07AM ET
AI, 5G and Robotic based futuristic nano capsule and the patents are irreplaceable. Should see @$99 in 1sr half 2021.
Bionano Genomics Feb 03, 2021 11:55AM ET
1/3 human dies by cancer. BNGO provides game changing solutions for cancer detection and prevention soon. @$2,000 by 2023.
Vyne Therapeutics Feb 02, 2021 12:50PM ET
AMZEEQ is finally approved by FDA. Now VYNE will distribute worldwide. It is time to harvest after significant R&D over the last 5 years. Inside managements are buying huge volume. Last train to jump in.
Vyne Therapeutics Feb 02, 2021 9:49AM ET
Actually VYNE made a breakthrough the limit from my further research. The platform is beyond imagination for unlimited growth. @$50~100 by 2021 seems an easy target prospect.
Asensus Surgical Feb 02, 2021 8:51AM ET
Most FDA approvals are completed for distribution of the most advanced ISU based on AI, 5G, Robotics. Extra 3 more K510 FDAs left for extra function during operation. Will be surprised if $200~300 not reached by 2021.
Bionano Genomics Feb 02, 2021 8:40AM ET
BNGO is now leading AI, 5G, Deep Learning based future Genome technology company for the wellbeing of all living existence.
Vyne Therapeutics Feb 02, 2021 8:17AM ET
Extreamly overvalued. Great R&D, Admin losses till next 3~5 years. No tangible achievement. Target @$0.8~1.2 max.
Microvast Holdings Feb 01, 2021 2:40PM ET
Get the profit as it will drop back tomorrow...